AI assistant
Sending…
CHEVRON CORP — Director's Dealing 2007
May 7, 2007
29758_dirs_2007-05-07_c103d2a6-c167-4d0a-8c60-f49ecb0e2bde.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CHEVRON CORP (CVX)
CIK: 0000093410
Period of Report: 2007-05-03
Reporting Person: BETHANCOURT JOHN E (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-05-03 | Common Stock | M | 1678 | $67.14 | Acquired | 66855 | Direct |
| 2007-05-03 | Common Stock | S | 1678 | $79.684 | Disposed | 65177 | Direct |
| 2007-05-03 | Common Stock | S | 1470 | $79.6802 | Disposed | 63707 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-05-03 | Non-Qualified Stock Option (Right to Buy) | $67.14 | M | 1678 | Disposed | 2007-07-01 | Common Stock (1678) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 32223 | Indirect |
Footnotes
F1: This number includes dividend equivalent accruals (145 shares) from awards granted under the Chevron Long-Term Incentive Plan.
F2: Between February 28, 2007 and May 3, 2007, the reporting person acquired 391 shares of Chevron Corporation common stock under the Chevron Employee Savings Investment Plan, a 401(k) plan.
F3: This transaction is an exercise of a non-qualified stock option and the conversion price is reported in column 2.
More from CHEVRON CORP
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Board/Management Information
2026
May 29
Regulatory Filings
2026
May 8
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 9
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7